STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway.

MLA

Wang, Ran, et al. “STAT3-NAV2 Axis as a New Therapeutic Target for Rheumatoid Arthritis via Activating SSH1L/Cofilin-1 Signaling Pathway.” Signal Transduction and Targeted Therapy, vol. 7, no. 1, July 2022, p. 209. EBSCOhost, https://doi.org/10.1038/s41392-022-01050-7.

APA

Wang, R., Cai, J., Chen, K., Zhu, M., Li, Z., Liu, H., Liu, T., Mao, J., Ding, Q., & Zhu, Y. Z. (2022). STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway. Signal Transduction and Targeted Therapy, 7(1), 209. https://doi.org/10.1038/s41392-022-01050-7

Chicago

Wang, Ran, Jianghong Cai, Keyuan Chen, Menglin Zhu, Zhaoyi Li, Hua Liu, Tiantian Liu, Jianchun Mao, Qian Ding, and Yi Zhun Zhu. 2022. “STAT3-NAV2 Axis as a New Therapeutic Target for Rheumatoid Arthritis via Activating SSH1L/Cofilin-1 Signaling Pathway.” Signal Transduction and Targeted Therapy 7 (1): 209. doi:10.1038/s41392-022-01050-7.